On January 28, 2025, President Trump signed Government Order 14187 (the “EO”), which directed the federal authorities to take steps to make sure that the federal authorities doesn’t “sponsor, promote, help, or assist” the “‘transition’ of a kid from one intercourse to a different,” together with the availability of gender-affirming care to people below the age of 19. Particular provisions of the EO directed, amongst different issues, that: (1) all federal businesses rescind or amend all insurance policies counting on steerage issued by the World Skilled Affiliation for Transgender Well being; (2) federal businesses that present analysis or schooling grants to hospitals and medical faculties take “applicable steps” to make sure that establishments receiving federal analysis or schooling grants finish gender-affirming care to people below the age of 19; (3) the Secretary of the Division of Well being and Human Companies (“HHS”) take all applicable regulatory and authorized motion to finish gender-affirming care for people below the age of 19—resembling by Medicare or Medicaid circumstances of participation or circumstances for protection, clinical-abuse or inappropriate-use assessments related to State Medicaid applications; (4) the U.S. Lawyer Normal to implement an present federal regulation towards “genital mutilation” (18 U.S.C. § 116), and coordinate with state attorneys common to implement state legal guidelines towards gender-affirming care; and (5) the Director of the Workplace of Personnel Administration embrace provisions within the Federal Worker Well being Advantages and Postal Service Well being Advantages applications name letter for the 2026 plan yr specifying that eligible carriers exclude protection for pediatric transgender surgical procedures or hormone remedies.
Federal Authorities Responses
The provisions of the EO associated to analysis and schooling grants have been enjoined by two totally different federal courts (that are pending on attraction): (1) within the Western District Courtroom of Washington, with the injunction solely to use to the states of Washington, Minnesota, Oregon, and Colorado, and (2) within the District Courtroom of Maryland, with the injunction making use of nationwide, although an emergency order to implement the injunction was denied on March 28, 2025. Nonetheless, federal businesses have already taken actions to implement the opposite provisions of the EO. On January 31, 2025, in accordance with the EO, the U.S. Workplace of Personnel Administration (“OPM”) issued Provider Letter Quantity 2025-01A, instructing insurance coverage carriers for federal staff and postal employees (every provider for federal staff, a “FEHB Provider”, and every provider for postal employees, a “PSHB Provider”) to “‘exclude protection for pediatric transgender surgical procedures or hormone remedies’ for the aim of gender transition” for lined people below the age of 19 for the plan yr of 2026. Remedies excluded below this coverage embrace “remedies prescribed for the aim of delaying the onset or development of usually timed puberty (together with GnRH agonists),” “use of androgen blockers, estrogen, progesterone, and testosterone to align a person’s bodily look with an id that differs from his or her intercourse,” and “surgical procedures used to align a person’s bodily look with an id that differs from his or her intercourse”. The letter does permit protection for surgical procedures or hormone remedies that are supposed to facilitate gender transition for people above the age of 19, however it doesn’t require such protection. Carriers are required to adjust to this letter for the plan yr of 2026. OPM had beforehand issued Provider Letter Quantity 2023-12 on Might 23, 2023, stopping FEHB Carriers and PSHB Carriers from excluding from protection “providers associated to gender affirming care, resembling hormone remedy, genital surgical procedures, breast surgical procedures, and facial gender affirming surgical procedures”, which Provider Letter Quantity 2025-01A now supersedes.
Most lately, on April 11, 2025, the Facilities for Medicare and Medicaid Companies (“CMS”) issued a letter to State Medicaid Administrators reminding states that using federal funds obtained by the State Medicaid applications as a part of its federal monetary participation for protection of “procedures, remedies, or operations for the aim of rendering a person completely incapable of reproducing” is prohibited for these procedures if they’re carried out on an individual below the age of twenty-one (42 C.F.R. § 441.253(a)). The letter additionally reiterates the requirement that states keep a drug utilization program that complies with Part 1927 of the Social Safety Act (42 U.S.C. § 1396r-8) and implies that CMS will publish extra steerage on drug utilization program necessities concerning the prescription of medication for gender-affirming care remedies, however doesn’t at present implement any adjustments to the present necessities. As assist for its place, the letter cites research on the prevalence of gender affirming remedy and to a overview performed in the UK that discovered poor high quality of research on gender dysphoria and an absence of dependable proof to tell gender-based medical choices. CMS had beforehand issued a High quality & Security Particular Alert Memo on March 5, 2025, citing to the identical research because the April eleventh letter on the denoted risks and dangerous results of gender-affirming remedies.
HHS additionally lately agreed to drop its Biden-era attraction searching for to overturn a judicial order which prevented HHS from implementing anti-discrimination provisions of the Inexpensive Care Act (the “ACA”) with respect to transgender people in Florida. Beforehand, in 2024, HHS had revealed a Closing Rule with respect to Part 1557 of the ACA to make clear that such Part protected LGBTQ+ people by prohibiting entities receiving federal funding, together with healthcare suppliers, from discriminating towards transgender people. The State of Florida, a number of Florida authorities businesses, and the Catholic Medical Affiliation filed swimsuit and have been granted an injunction which blocks the imposition of the anti-discrimination provisions in Florida. Underneath Biden, HHS appealed the injunction. Nonetheless, on the request of HHS, the Courtroom of Appeals for the Eleventh Circuit dismissed the attraction on April 3, 2025. This follows a comparable dismissal within the Courtroom of Appeals for the Fifth Circuit, the place HHS dropped its attraction of a nationwide injunction in Tennessee and a Texas- and Montana-specific injunction in Texas. Because of this, HHS might not implement the anti-discrimination provisions within the ACA with respect to transgender people and accordingly, entities receiving federal funds, together with sure Medicare funds, might face a low danger of enforcement by HHS on account of denying care or protection to transgender people.
Parallel State Authorities Actions
Whereas the EO applies solely to federal businesses, many states have additionally moved to reinstitute state-level prohibitions on gender-affirming care. On April 3, 2025, Ohio Lawyer Normal Dave Yost appealed to the Supreme Courtroom of Ohio to overturn a court docket order which blocks enforcement of a regulation stopping using hormone or puberty blocking remedies for transgender people below the age of eighteen, and in addition requested the Courtroom prohibit any injunctive reduction whereas the attraction is pending. The regulation had beforehand been handed over Governor Mike DeWine’s veto in January of 2024. If profitable, medical doctors in Ohio can be prohibited from offering gender affirming hormone or puberty blocking remedies for transgender people below the age of eighteen.
In complete since 2021 and as of March 19, 2025, twenty-seven states have handed bans on gender-affirming healthcare: Idaho, Utah, Montana, Wyoming, North Dakota, South Dakota, Nebraska, Kansas, Oklahoma, Texas, Iowa, Missouri, Arkansas, Louisiana, Kentucky, Tennessee, Mississippi, Indiana, West Virginia, South Carolina, Alabama, Ohio, North Carolina, Georgia, and Florida have banned gender-affirming care whether or not by medicine and surgical procedures, whereas Arizona and New Hampshire have solely banned gender affirming surgical care (although Governor Katie Hobbs of Arizona issued an government order permitting transgender state staff to obtain insurance coverage protection for gender-affirming healthcare providers). A problem to Tennessee’s ban on gender-affirming care is at present pending earlier than the U.S. Supreme Courtroom. America had initially filed briefs in assist of the unique plaintiffs within the case arguing that the Tennessee regulation violated the Equal Safety Clause of the Fourteenth Modification, however in a letter dated February 7, 2025, the U.S. Division of Justice modified its place to state that it not holds the view that the Tennessee regulation violates the Fourteenth Modification, however that the case shouldn’t be dismissed so {that a} ruling on the equal safety query will present steerage to many circumstances at present pending within the decrease courts.
Not all states, nonetheless, have enacted comparable laws. The District of Columbia and the next sixteen states have enacted a wide range of protections for gender-affirming care, together with “protect” legal guidelines to guard suppliers towards enforcement actions initiated by different states that impose bans on gender-affirming care and necessary insurance coverage protection for gender-affirming care procedures by utility of state non-discrimination legal guidelines: Washington, Oregon, California, Arizona (although per the above government order entry is restricted solely to state staff), Colorado, New Mexico, Minnesota, Illinois, Maryland, New York, New Jersey, Connecticut, Vermont, Rhode Island, Massachusetts, and Maine. Moreover, a number of state attorneys common, together with the state attorneys common of California and New York, have despatched letters to particular person healthcare suppliers warning them that withholding medical providers from transgender people on the premise of their gender id may violate state anti-discrimination legal guidelines.
Notably, on April 4, 2025, eleven states filed an amicus curiae transient in assist of a lawsuit earlier than the Courtroom of Appeals for the Sixth Circuit searching for to overturn Michigan’s ban on conversion remedy for minors. Michigan state regulation prohibits remedy supposed to alter an individual’s sexual orientation or gender identification “together with however not restricted to, efforts to alter habits or gender expression or to scale back or get rid of sexual or romantic sights or emotions towards a person of the identical gender,” sometimes called conversion remedy. The plaintiffs within the preliminary lawsuit argued that the ban unconstitutionally prohibited therapists’ freedom of speech. A federal court docket decide for the Western District of Michigan discovered that the Michigan regulation doesn’t intrude on a therapist’s First Modification proper and upheld the prohibition on conversion remedy. The plaintiffs then appealed to the Sixth Circuit. Whereas this case doesn’t immediately contain gender-affirming care, all the states that are celebration to the amicus curiae transient have carried out bans on gender-affirming care.
Because the authorized and political panorama continues to evolve, healthcare organizations and healthcare suppliers that provide gender-affirming care might face important new authorized, regulatory and monetary dangers, notably the place there may be the potential for battle between federal necessities and state legal guidelines. Even within the absence of direct battle, there are important variations between the EO’s said goals and state regulation restrictions on gender-affirming care, resembling the desired age vary to which the legal guidelines apply. The potential complexities and penalties ensuing from such variations make it crucial that healthcare organizations and healthcare suppliers pay cautious consideration to developments regarding restrictions on gender-affirming care and seek the advice of authorized counsel as mandatory.